Aromatase and its inhibitors in breast cancer treatment — overview and perspective Angela M. H. BrodieRichard J. Santen OriginalPaper Pages: 1 - 6
Regulation of aromatase expression in human tissues Serdar E. BulunEvan R. Simpson OriginalPaper Pages: 19 - 29
Aromatase inhibitors — mechanisms of steroidal inhibitors Robert W. Brueggemeier OriginalPaper Pages: 31 - 42
Aromatase inhibitors — mechanisms for non-steroidal inhibitors Hugo Vanden BosscheHenri MoereelsLuc M. H. Koymans OriginalPaper Pages: 43 - 55
First generation aromatase inhibitors — aminoglutethimide and testololactone Giorgio Cocconi OriginalPaper Pages: 57 - 80
Second generation aromatase inhibitor — 4-hydroxyandrostenedione M. DowsettR. C. Coombes OriginalPaper Pages: 81 - 87
Vorozole, a specific non-steroidal aromatase inhibitor Walter WoutersEric SnoeckRoland De Coster OriginalPaper Pages: 89 - 94
Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients Laurence M. Demers OriginalPaper Pages: 95 - 102
Arimidex®: A potent and selective fourth-generation aromatase inhibitor Paul V. PlourdeMartin DyroffMichael Dukes OriginalPaper Pages: 103 - 111